Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06751953
What this trial is testing

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)UnknownNCT02596256
What this trial is testing

Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 80
Large-scale testing (Phase 3)Ended earlyNCT00198328
What this trial is testing

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head Neck Cancer
Inovio Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Study completedNCT00336856
What this trial is testing

Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy

Who this might be right for
Colon CancerRectum Cancer
University of Pittsburgh 35
Not applicableUnknownNCT06523322
What this trial is testing

Culinary Medicine for Cancer Caregivers

Who this might be right for
Pediatric CancerCaregiver BurdenCancer, Treatment-Related+1 more
Drexel University 20
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)Study completedNCT01168973
What this trial is testing

Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 1,253
Not applicableLooking for participantsNCT06816095
What this trial is testing

Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment

Who this might be right for
Chronic Pelvic Pain Syndrome (CPPS)Radiation-Induced DisorderRadiotherapy Side Effects+2 more
Bernardino Clavo, MD, PhD 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815197
What this trial is testing

Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer

Who this might be right for
Penile Squamous Cell CarcinomaMetastatic Penile Squamous Cell Carcinoma
Latin American Cooperative Oncology Group 37
Large-scale testing (Phase 3)Study completedNCT00295620
What this trial is testing

Secondary Adjuvant Long Term Study With Arimidex

Who this might be right for
Breast Cancer
AstraZeneca 3,484
Testing effectiveness (Phase 2)Ended earlyNCT00392782
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 24
Testing effectiveness (Phase 2)Study completedNCT03669523
What this trial is testing

Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS)

Who this might be right for
Carcinoma, Non-Small-Cell LungBone Metastases
Centre Hospitalier Annecy Genevois 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015659
What this trial is testing

ZN-c3 + Gemcitabine in Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaPancreatic CancerPancreatic Ductal Adenocarcinoma
Brandon Huffman, MD 12
Testing effectiveness (Phase 2)Study completedNCT04770623
What this trial is testing

Docetaxel and Irinotecan in Gastric Cancer

Who this might be right for
Stomach CancerGastric CancerChemotherapy Effect
Menoufia University 32
Not applicableUnknownNCT02328391
What this trial is testing

STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE

Who this might be right for
Carcinoma, Squamous Cell
Grupo Gallego de Cancer de Pulmon 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07361991
What this trial is testing

IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Who this might be right for
Advan'ce'dAdvanced
The First Affiliated Hospital of Zhengzhou University 50
Testing effectiveness (Phase 2)Study completedNCT01064713
What this trial is testing

Phase II Study of Tesetaxel in Metastatic Melanoma

Who this might be right for
Advanced MelanomaCancer
M.D. Anderson Cancer Center 17
Not applicableStudy completedNCT00897078
What this trial is testing

Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings

Who this might be right for
Leukemia
Vanderbilt University 39
Next Page